2-(2-Chloro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

(5S,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)tetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, 97%, 1g

Thalidomide-O-amido-PEG2-C2-NH2 (TFA), 500mg

5-(Bromomethyl)-1,2,3-trimethoxybenzene, 95.0%, 1g

(1E,4E)-1,5-Bis(2-hydroxyphenyl)penta-1,4-dien-3-one, 1g

Sodium thiophene-2-carboxylate, 95.0%, 10g

Cyclopentylsulfonyl chloride, 95.0%, 50mg

Phenoxypolyethylene Glycol Acrylate (n=approx. 2) (stabilized with MEHQ)500g

3-cyanobicyclo[1.1.1]pentane-1-carboxylic acid, 95.0%, 250mg

TRIOCTANOIN, 95%, 25g

Methyl 2-((trimethylsilyl)ethynyl)benzoate, 95%, 500mg

ClickTech EdU Kit 594, L, pour l'imagerie, in vivo, 1 kit, carton

5-(difluoromethyl)-1H-pyrazole-4-carboxylic acid, 97%, 250mg